Nuclear Medicine Equipment Market 2022-2027: Scope, Trends, Share, Demand And Outlook
According to the latest report by IMARC Group, titled “Nuclear Medicine Equipment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027,” The global nuclear medicine equipment market size reached US$ 2.7 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 4 Billion by 2027, exhibiting at a CAGR of 6.8% during 2022-2027.
Nuclear medicine equipment is a medical device, which is utilized extensively in the healthcare industry for treating and diagnosing several diseases, such as cancer, and cardiovascular and neurological disorders, by generating anatomical images. These devices are further used for developing drugs and examining various processes of tissue blood flow, cell receptor expression, neurotransmitter activity, abnormal cell and metabolism of the patient.
Request for a free sample copy of this report: https://www.imarcgroup.com/nuclear-medicine-equipment-market/requestsample
Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
The increasing requirement for personalized medicines in the healthcare sector and the rising prevalence of chronic diseases amongst the geriatric population are primarily driving the nuclear medicine equipment market. Moreover, the widespread adoption of various technologically advanced systems, such as radiotracers and imaging systems and significant investments in research and development (R&D) activities in the field of biotechnology are propelling the market growth. Other factors, such as overall improvement in the medical infrastructure and the rising utilization of position emission tomography (PET) and single-photon emission computed tomography (SPECT) for capturing accurate nuclear medicine imaging, are creating a positive outlook in the market across the globe.
Breakup by Product:
- Single-Photon Emission Computed Tomography
- Positron Emission Tomography
- Planar Scintigraphy
Breakup by Application:
Breakup by End User:
- Imaging Centers
- Academic and Research Institutes
Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Competitive Landscape with Key Player:
- Biodex Medical Systems Inc. (Mirion Technologies Inc.)
- Cardinal Health Inc
- CMR Naviscan Corporation
- DD-Diagnostic A/S
- Digirad Corporation
- General Electric Company
- Koninklijke Philips N.V
- Mediso Ltd
- Neusoft Corporation
- Siemens AG
- SurgicEye GmbH
- Toshiba Corporation
Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/nuclear-medicine-equipment-market
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: [email protected]
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800